Abpro announced that it has received formal notification from the Nasdaq Hearings Panel granting the Company an extension to allow additional time to regain full compliance with Nasdaq listing requirements. In addition to the reverse stock split which took effect recently on November 3, Abpro’s compliance roadmap includes a market transfer application and planned capital strategy to increase stockholders’ equity to maintain listing compliance. The Company has access to up to $44 million in equity financing, which it may utilize to fund operations and achieve long-term financial milestones.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABP:
- Abpro Holdings files to sell 9.78M shares of common stock for holders
- Abpro Holdings, Celltrion to present preclinical data for CT-P72/ABP-102
- Abpro Holdings Presents Promising Preclinical Data at SITC 2025
- Abpro Holdings Announces Reverse Stock Split Effectiveness
- Abpro Holdings announces 1-for-30 reverse stock split